Loading company…
Malignant Tumor Treatment Technologies develops treatments for malignant tumors.
Founded in 2018 and based in Sakai-shi, Japan, Malignant Tumor Treatment Technologies develops cancer treatments, including its Levritin® product. In June 2022, it raised an undisclosed amount of growth funding from Wing Capital Partners and Gunma Regional Advanced Solution Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in